Written answers

Tuesday, 9 July 2013

Department of Health

Vaccination Programme

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

533. To ask the Minister for Health following the vaccine named Bexero being approved for use by the European Commission in January 2013, if there are any plans to approve and introduce the use of this vaccine here in the near future; and if he will make a statement on the matter. [33336/13]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

534. To ask the Minister for Health if the level of infection of meningitis B here, being the highest in Europe, has been taken into account in respect of the decision on the use of the vaccine named Bexero for the treatment of meningitis B here; and if he will make a statement on the matter. [33337/13]

Photo of James ReillyJames Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 533 and 534 together.

The immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland comprising of experts in a number of specialties including infectious diseases, paediatrics and public health. The committee's recommendations are informed by public health advice, international best practice and by the National Centre for Pharmacoeconomics (NCPE). A Health Technology Assessment which includes a cost benefit analysis is carried out prior to any new vaccine being considered. This has a vital role in ensuring that care technologies, including vaccines, are used in a manner appropriate to their ability to maximise health gain and achieve value for money. Should NIAC advice recommend the inclusion of a new vaccine into the primary childhood immunisation programme in Ireland, my Department, in association with the Health Service Executive's National Immunisation Office will examine the issue.

Comments

No comments

Log in or join to post a public comment.